Upwallstreet Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is ...

Moderna’s shares climbed in the first half of the year, as it scored victories with a product approval and solid clinical trial results. This week the biotech surprised investors with some ...

The Montville Police Department has released the name of the man who was found dead in a body of water this weekend. The man was identified as Valeri Malov, 64, of the Pine Brook section of ...

Moderna, the Massachusetts-based biotech company that rocketed into the global spotlight during the development of its COVID-19 vaccine, announced plans on Thursday to cut costs and refocus on ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines ...

Montville ― The police department has announced it will conduct sobriety checkpoints in various locations in town beginning Friday night. The checks will take place between 5 p.m. Friday and 4 a ...

Aug. 23—MONTVILLE — A police officer who used a homophobic slur and profanity toward a suspect during an arrest last year has received a verbal warning and was required to attend a one-hour ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who have viewed the company’s ...

Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna MRNA revealed 19 unusual trades. Delving into the details, we found 42% of traders ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Moderna, Inc.'s combination flu and COVID-19 vaccine, mRNA-1083, showed strong Phase 3 results in adults over 50. Pfizer/BioNTech's combination vaccine faced setbacks, giving Moderna a potential ...